Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000061

President and CEO sold 9,589 shares at $17.29 ($165,794)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-13 Sale : show line 1 in the form −9,589 $17.29 $165,794 238,067 D
Open-market sales · 9,589 sh · avg $17.29 · $165,794
Loading xslF345X05/wk-form4_1708049710.xml…